T-Cypher Bio Announces Formation of Scientific Advisory Board
July 29, 2021 07:00 ET
|
T-Cypher Bio
PRESS RELEASE T-Cypher Bio Announces Formation of Scientific Advisory Board Oxford, UK, 29 July 2021 – T-Cypher Bio (‘T-Cypher’, or ‘the Company’), a rapidly emerging private biotech company...
T-Cypher Bio announces the appointment of Thomas Lars Andresen as Chief Executive Officer
July 15, 2021 07:00 ET
|
T-Cypher Bio
PRESS RELEASE T-Cypher Bio announces the appointment of Thomas Lars Andresen as Chief Executive Officer Company to be led by award winning, cell therapy expert as it aims to unlock an expansive...
T-Cypher Bio separates from Orbit Discovery to build a pipeline of TCR therapeutics for solid tumours and other indications
February 25, 2021 07:00 ET
|
T-Cypher Bio
PRESS RELEASE T-Cypher Bio separates from Orbit Discovery to build a pipeline of TCR therapeutics for solid tumours and other indications Company has potential to unlock an expansive therapeutic...